Ignite Creation Date:
2024-05-05 @ 11:05 PM
Last Modification Date:
2024-10-26 @ 10:28 AM
Study NCT ID:
NCT01253317
Status:
COMPLETED
Last Update Posted:
2017-06-22
First Post:
2010-12-02
Brief Title:
Treatment of Rett Syndrome With rhIGF-1 Mecasermin rDNAInjection
Sponsor:
Boston Childrens Hospital
Organization:
Boston Childrens Hospital
Organization Data
Organization:
Boston Childrens Hospital
Class:
OTHER
Study ID:
10-08-0403
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boston Childrens Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Mustafa Sahin
Responsible Party Title:
Professor in Neurology Harvard Medical School
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Boston Childrens Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Autism Speaks | OTHER |
| International Rett Syndrome Foundation | OTHER |